Cleared Traditional

RF Cannula

Jan 2025
Decision
254d
Days
Class 2
Risk

About This 510(k) Submission

K241367 is an FDA 510(k) clearance for the RF Cannula, a Probe, Radiofrequency Lesion (Class II — Special Controls, product code GXI), submitted by Shanghai Samedical & Plastic Instruments Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on January 23, 2025, 254 days after receiving the submission on May 14, 2024. This device falls under the Neurology review panel. Regulated under 21 CFR 882.4725.

Submission Details

510(k) Number K241367 FDA.gov
FDA Decision Cleared SESE
Date Received May 14, 2024
Decision Date January 23, 2025
Days to Decision 254 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXI — Probe, Radiofrequency Lesion
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.4725

Similar Devices — GXI Probe, Radiofrequency Lesion

All 64
STAR RF Ablation System
K251802 · Merit Medical Systems, Inc. · Feb 2026
OneRF Trigeminal Nerve Radiofrequency Probes
K251243 · Neuroone Medical Technologies Corp. · Aug 2025
Disposable RF Electrode (RFDE-5/RFDE-10/RFDE-15/RFDE-20)
K242841 · Abbott Medical · May 2025
OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Single Kit); OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Dual Kit)
K250213 · Stryker Instruments · May 2025
Intracept Intraosseous Nerve Ablation System
K222281 · Relievant Medsystems, Inc. · Oct 2022
Intracept Intraosseous Nerve Ablation System
K213836 · Relievant Medsystems, Inc. · Mar 2022